Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer.

Autor: Nguyen Van Long F; Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Léon Bérard Cancer Centre, Cheney A, 28 rue Laennec, 69373 cedex 08, Lyon, France.; Institut Convergence PLAsCAN, 69373 cedex 08, Lyon, France.; DevWeCan Labex Laboratory, 69373 cedex 08, Lyon, France., Lardy-Cleaud A; Biostatistics Unit, Department of Clinical Research, Léon Bérard Cancer Centre, 28 rue Laennec, 69008, Lyon, France., Carène D; Predictive Biomarkers and Novel Therapeutic Strategies Group, Institut Gustave Roussy, University of Paris Sud, INSERM 981, Université Paris Saclay, 114 rue Edouard Vaillant, 94800, Villejuif, France.; Department of Biostatistics and Epidemiology, Institut Gustave Roussy, 94800, Villejuif, France., Rossoni C; Department of Biostatistics and Epidemiology, Institut Gustave Roussy, 94800, Villejuif, France., Catez F; Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Léon Bérard Cancer Centre, Cheney A, 28 rue Laennec, 69373 cedex 08, Lyon, France.; Institut Convergence PLAsCAN, 69373 cedex 08, Lyon, France.; DevWeCan Labex Laboratory, 69373 cedex 08, Lyon, France., Rollet P; Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Léon Bérard Cancer Centre, Cheney A, 28 rue Laennec, 69373 cedex 08, Lyon, France.; Institut Convergence PLAsCAN, 69373 cedex 08, Lyon, France.; DevWeCan Labex Laboratory, 69373 cedex 08, Lyon, France., Pion N; Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Léon Bérard Cancer Centre, Cheney A, 28 rue Laennec, 69373 cedex 08, Lyon, France.; Institut Convergence PLAsCAN, 69373 cedex 08, Lyon, France.; DevWeCan Labex Laboratory, 69373 cedex 08, Lyon, France., Monchiet D; Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Léon Bérard Cancer Centre, Cheney A, 28 rue Laennec, 69373 cedex 08, Lyon, France.; Institut Convergence PLAsCAN, 69373 cedex 08, Lyon, France.; DevWeCan Labex Laboratory, 69373 cedex 08, Lyon, France., Dolbeau A; Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Léon Bérard Cancer Centre, Cheney A, 28 rue Laennec, 69373 cedex 08, Lyon, France.; Institut Convergence PLAsCAN, 69373 cedex 08, Lyon, France.; DevWeCan Labex Laboratory, 69373 cedex 08, Lyon, France., Martin M; Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Léon Bérard Cancer Centre, Cheney A, 28 rue Laennec, 69373 cedex 08, Lyon, France.; Institut Convergence PLAsCAN, 69373 cedex 08, Lyon, France.; DevWeCan Labex Laboratory, 69373 cedex 08, Lyon, France., Simioni V; Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Léon Bérard Cancer Centre, Cheney A, 28 rue Laennec, 69373 cedex 08, Lyon, France.; Institut Convergence PLAsCAN, 69373 cedex 08, Lyon, France.; DevWeCan Labex Laboratory, 69373 cedex 08, Lyon, France., Bray S; Tayside Tissue Bank, Ninewells Hospital and Medical School, NHS Tayside, Dundee, DD1 9SY, Scotland, UK., Le Beherec D; Department Translational Research, Institut Gustave Roussy, 94800, Villejuif, France., Mosele F; Predictive Biomarkers and Novel Therapeutic Strategies Group, Institut Gustave Roussy, University of Paris Sud, INSERM 981, Université Paris Saclay, 114 rue Edouard Vaillant, 94800, Villejuif, France., Bouakka I; Predictive Biomarkers and Novel Therapeutic Strategies Group, Institut Gustave Roussy, University of Paris Sud, INSERM 981, Université Paris Saclay, 114 rue Edouard Vaillant, 94800, Villejuif, France., Colombe-Vermorel A; Department of Translational Research and Innovation, Léon Bérard Cancer Centre, 28 rue Laennec, 69008, Lyon, France., Odeyer L; Department of Translational Research and Innovation, Léon Bérard Cancer Centre, 28 rue Laennec, 69008, Lyon, France., Diot A; Division of Cancer Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, Scotland, UK., Jordan LB; Department of Pathology, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, Scotland, UK., Thompson AM; Division of Cancer Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, Scotland, UK.; Olga Keith Wiess Chair of Surgery, Dan L. Duncan Breast Center, Division of Surgical Oncology, Baylor College of Medicine, Houston, TX, 77030, USA., Jamen F; Université Paris-Saclay Institute of Neuroscience, CNRS UMR9197, Gif-sur-Yvette, France.; Université Paris-Saclay, CIAMS, 91405, Orsay, Cedex, France., Dubois T; Breast Cancer Biology Group, Translational Research Department, Institut Curie-PSL Research University, 26 rue d'Ulm, 75005, Paris, France., Chabaud S; Biostatistics Unit, Department of Clinical Research, Léon Bérard Cancer Centre, 28 rue Laennec, 69008, Lyon, France., Michiels S; Department of Biostatistics and Epidemiology, Institut Gustave Roussy, 94800, Villejuif, France., Treilleux I; Department of Translational Research and Innovation, Léon Bérard Cancer Centre, 28 rue Laennec, 69008, Lyon, France., Bourdon JC; Division of Cancer Research, University of Dundee, Ninewells Hospital and Medical School, Dundee, DD1 9SY, Scotland, UK., Pérol D; Biostatistics Unit, Department of Clinical Research, Léon Bérard Cancer Centre, 28 rue Laennec, 69008, Lyon, France., Puisieux A; Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Léon Bérard Cancer Centre, Cheney A, 28 rue Laennec, 69373 cedex 08, Lyon, France.; DevWeCan Labex Laboratory, 69373 cedex 08, Lyon, France., André F; Predictive Biomarkers and Novel Therapeutic Strategies Group, Institut Gustave Roussy, University of Paris Sud, INSERM 981, Université Paris Saclay, 114 rue Edouard Vaillant, 94800, Villejuif, France., Diaz JJ; Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Léon Bérard Cancer Centre, Cheney A, 28 rue Laennec, 69373 cedex 08, Lyon, France. jean-jacques.diaz@lyon.unicancer.fr.; Institut Convergence PLAsCAN, 69373 cedex 08, Lyon, France. jean-jacques.diaz@lyon.unicancer.fr.; DevWeCan Labex Laboratory, 69373 cedex 08, Lyon, France. jean-jacques.diaz@lyon.unicancer.fr., Marcel V; Cancer Research Center of Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Léon Bérard Cancer Centre, Cheney A, 28 rue Laennec, 69373 cedex 08, Lyon, France. virginie.marcel@lyon.unicancer.fr.; Institut Convergence PLAsCAN, 69373 cedex 08, Lyon, France. virginie.marcel@lyon.unicancer.fr.; DevWeCan Labex Laboratory, 69373 cedex 08, Lyon, France. virginie.marcel@lyon.unicancer.fr.

Publikováno v: BMC cancer [BMC Cancer] 2022 May 11; Vol. 22 (1), pp. 526. Date of Electronic Publication: 2022 May 11.

Ribosomal RNA 2'O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer.

Autor: Marcel V; Univ Lyon, Université Claude Bernard Lyon 1, Inserm 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France., Kielbassa J; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, 69008 Lyon, France., Marchand V; UMS2008 IBSLor CNRS-INSERM-Lorraine University, Biopôle, 9 avenue de la forêt de haye, 54505 Vandoeuvre-les-Nancy, France., Natchiar KS; Centre for Integrative Biology (CBI), Department of Integrated Structural Biology, IGBMC, CNRS, Inserm, Université de Strasbourg, 1 rue Laurent Fries, 67404 Illkirch, France., Paraqindes H; Univ Lyon, Université Claude Bernard Lyon 1, Inserm 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France., Nguyen Van Long F; Univ Lyon, Université Claude Bernard Lyon 1, Inserm 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France., Ayadi L; UMS2008 IBSLor CNRS-INSERM-Lorraine University, Biopôle, 9 avenue de la forêt de haye, 54505 Vandoeuvre-les-Nancy, France., Bourguignon-Igel V; UMS2008 IBSLor CNRS-INSERM-Lorraine University, Biopôle, 9 avenue de la forêt de haye, 54505 Vandoeuvre-les-Nancy, France., Lo Monaco P; Univ Lyon, Université Claude Bernard Lyon 1, Inserm 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France., Monchiet D; Univ Lyon, Université Claude Bernard Lyon 1, Inserm 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France., Scott V; Predictive biomarkers and novel therapeutic strategies Group, Institut Gustave Roussy, University of Paris Sud, INSERM 981, Université Paris Saclay, 114 rue Edouard Vaillant, 94800 Villejuif, France., Tonon L; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, 69008 Lyon, France., Bray SE; Tayside Tissue Bank, Ninewells Hospital and Medical School, NHS Tayside, Dundee DD1 9SY, Scotland, UK., Diot A; Division of Cancer Research, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, UK., Jordan LB; Department of Pathology, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK., Thompson AM; Division of Cancer Research, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, UK., Bourdon JC; Division of Cancer Research, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, UK., Dubois T; Breast Cancer Biology Group, Translational Research Department, Institut Curie-PSL Research University, 26 rue d'Ulm, 75005 Paris, France., André F; Predictive biomarkers and novel therapeutic strategies Group, Institut Gustave Roussy, University of Paris Sud, INSERM 981, Université Paris Saclay, 114 rue Edouard Vaillant, 94800 Villejuif, France., Catez F; Univ Lyon, Université Claude Bernard Lyon 1, Inserm 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France., Puisieux A; Univ Lyon, Université Claude Bernard Lyon 1, Inserm 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France., Motorin Y; UMS2008 IBSLor CNRS-INSERM-Lorraine University, Biopôle, 9 avenue de la forêt de haye, 54505 Vandoeuvre-les-Nancy, France., Klaholz BP; Centre for Integrative Biology (CBI), Department of Integrated Structural Biology, IGBMC, CNRS, Inserm, Université de Strasbourg, 1 rue Laurent Fries, 67404 Illkirch, France., Viari A; Synergie Lyon Cancer, Gilles Thomas Bioinformatics Platform, Centre Léon Bérard, 69008 Lyon, France., Diaz JJ; Univ Lyon, Université Claude Bernard Lyon 1, Inserm 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008 Lyon, France.

Publikováno v: NAR cancer [NAR Cancer] 2020 Dec 22; Vol. 2 (4), pp. zcaa036. Date of Electronic Publication: 2020 Dec 22 (Print Publication: 2020).

Mitochondrial Ribosomal Protein MRPS15 Is a Component of Cytosolic Ribosomes and Regulates Translation in Stressed Cardiomyocytes.

Autor: David, Florian¹ (AUTHOR) davidflorian31@hotmail.fr, Roussel, Emilie¹ (AUTHOR) emilieroussel55@gmail.com, Froment, Carine^2,3 (AUTHOR) carine.froment@ipbs.fr, Draia-Nicolau, Tangra¹ (AUTHOR) dn.tangra27@gmail.com, Pujol, Françoise¹ (AUTHOR) francoise.pujol@inserm.fr, Burlet-Schiltz, Odile^2,3 (AUTHOR) odile.schiltz@ipbs.fr, Henras, Anthony K.⁴ (AUTHOR) anthony.henras@univ-tlse3.fr, Lacazette, Eric¹ (AUTHOR) eric.lacazette@inserm.fr, Morfoisse, Florent¹ (AUTHOR) florent.morfoisse@inserm.fr, Tatin, Florence¹ (AUTHOR) florence.tatin@inserm.fr, Diaz, Jean-Jacques⁵ (AUTHOR) jeanjacques.diaz@lyon.unicancer.fr, Catez, Frédéric⁵ (AUTHOR) frederic.catez@lyon.unicancer.fr, Garmy-Susini, Barbara¹ (AUTHOR) barbara.garmy-susini@inserm.fr, Prats, Anne-Catherine¹ (AUTHOR) anne-catherine.prats@inserm.fr

Publikováno v: International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 6, p3250. 26p.

The identification of hub genes associated with pure ground glass nodules using weighted gene co-expression network analysis.

Autor: Cheng, Yuan, Song, Zuoqing

Publikováno v: BMC Pulmonary Medicine; 6/10/2024, Vol. 24 Issue 1, p1-12, 12p

Ribosomal Dysregulation in Metastatic Laryngeal Squamous Cell Carcinoma: Proteomic Insights and CX-5461's Therapeutic Promise.

Autor: Gao, Miao, Liu, Ting, Hu, Kairui, Chen, Songling, Wang, Shixin, Gan, Di, Li, Zhihan, Lin, Xiaohuang

Publikováno v: Toxics; May2024, Vol. 12 Issue 5, p363, 19p